Get Sample Pages - Vietnam Diagnostic Tests Market Size, Share

Vietnam Diagnostic Tests Market Research Report: Forecast (2025-2030)

Diagnostic Tests Market in Vietnam - By Product Type (Immunoassay-Based Diagnostic Tests, Molecular Diagnostic Tests, Clinical Chemistry Diagnostic Tests, Hematology Diagnostic Tes......ts, Microbiology Diagnostic Tests, Rapid/Point-of-Care Diagnostic Tests, Others), By End Users (Hospital-Based Laboratories, Diagnostic Centers/Stand-alone Labs, Clinics, Home Care, Research Institutes) and Others Read more

Healthcare
Jul 2025
Pages 128
Report Format: PDF, Excel, PPT

Market Insights & Analysis: Vietnam Diagnostic Tests Market (2025-30):

The Vietnam Diagnostic Tests Market size was valued at around USD 1.84 billion in 2024 and is expected to reach USD 6.79 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 24.31% during the forecast period, i.e., 2025-30. The Vietnam Diagnostic Tests Market is significantly growing due to several growth factors, including the high incidence of chronic diseases, like cardiovascular diseases, kidney disorders, diabetes, hypertension, infectious diseases, and many more in the country, the rising government support through significant investments, the rapid shift towards digitalization, the adoption of technological advancement like AI with the diagnostic tools and software, etc. One of the major growth factors is the rising public awareness about early disease detection for better treatments is increasing the number of regular checkups and screenings, thus uplifting the market size & volume.

Report Coverage	Details
Historical Years	2020–23
Base Years	2024
Forecast Years	2025–30
Market Value in 2024	USD 1.84 Billion
Market Value by 2030	USD 6.79 Billion
CAGR (2025–30)	24.31%
Top Key Players	Roche Vietnam Co., Ltd., Siemens Healthineers (Vietnam) Co., Ltd., Abbott Laboratories S.A. (Vietnam), Danaher Corporation (Beckman Coulter Vietnam), Becton, Dickinson and Company (BD Vietnam), Thermo Fisher Scientific (Vietnam), Bio-Rad Laboratories (Vietnam), Medtronic Vietnam, Viet A Corporation, Medicon Co., Ltd, Sao Thai Duong Joint Stock Company, and others
Segmentation	By Product Type (Immunoassay-Based Diagnostic Tests, Molecular Diagnostic Tests, Clinical Chemistry Diagnostic Tests, Hematology Diagnostic Tests, Microbiology Diagnostic Tests, Rapid/Point-of-Care Diagnostic Tests, Others), By End Users (Hospital-Based Laboratories, Diagnostic Centers/Stand-alone Labs, Clinics, Home Care, Research Institutes) and Others
Key Report Highlights	Market Dimensions & Projections Pricing Evaluation Recent Strategic Moves by Companies Primary Stakeholders Import/Export Trend Analysis Competitive Landscape Assessment Emerging Opportunities Market Trends and Indicators

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Additionally, the Vietnamese government is actively supporting the market growth by heavily investing in the expansion of the healthcare infrastructure and the medical device industry in the country. These substantial funds are allocated by the government through various policies, such as the National Strategy for Healthcare Development under Vision 2045, the National Pharmaceutical Industry Strategy, the Law of Health Insurance & law on Pharmacy, and the Law on Medical Examination & Treatment. Such kind of support offers ample growth opportunities for this market to grow further. Moreover, the adoption of artificial intelligence in the healthcare industry and the rising inclination towards digitalization are actively transforming the market. However, the high cost of the diagnostic tests and the limited infrastructure are restraining the market growth & expansion.

Vietnam Diagnostic Tests Market Driver:

Rising Prevalence of Chronic Diseases Driving Market Growth – The high incidence of chronic diseases, like diabetes, cardiovascular disease, cancer, respiratory diseases, kidney disorders, liver disease, and many more in the country, is driving the market growth. For instance, in 2024, approximately 7 million Vietnamese citizens were diagnosed with diabetes. Similarly, as of 2024, around 12 million people in the country are living with hypertension, contributing to the market growth.

Additionally, every year, almost 2,00,000 new cancer cases are added in the country, which is confirmed by various diagnostic tests such as biopsies, molecular diagnostics, etc., thus increasing the market demand. Also, the major cause of death in Vietnam is the high prevalence of cardiovascular diseases, which is responsible for about 30% of the total deaths per year. Moreover, about 12% of the country’s population has chronic kidney disease as of 2024. Likewise, the high prevalence of many other chronic diseases is increasing the diagnostic testing market in the country.

Market Segmentation
Introduction
1. Product Definition
2. Research Process
3. Assumptions
Executive Summary
Vietnam Diagnostic Tests Market Policies, Regulations, and Product Standards
Vietnam Diagnostic Tests Market Supply Chain Analysis
Vietnam Diagnostic Tests Market Trends & Developments
Vietnam Diagnostic Tests Market Dynamics
1. Growth Drivers
2. Challenges
Vietnam Diagnostic Tests Market Hotspot & Opportunities
Vietnam Diagnostic Tests Market Outlook, 2020–2030
1. Market Size & Outlook
  1. By Revenues (USD Million)
  2. By Volume (Million Units)
    1. By Product Type
      1. Immunoassay-Based Diagnostic Tests- Market Size & Forecast 2020–2030, USD Million
      2. Molecular Diagnostic Tests- Market Size & Forecast 2020–2030, USD Million
      3. Clinical Chemistry Diagnostic Tests- Market Size & Forecast 2020–2030, USD Million
      4. Hematology Diagnostic Tests- Market Size & Forecast 2020–2030, USD Million
      5. Microbiology Diagnostic Tests- Market Size & Forecast 2020–2030, USD Million
      6. Rapid/Point-of-Care Diagnostic Tests- Market Size & Forecast 2020–2030, USD Million
      7. Others
    2. By End Users
      1. Hospital-Based Laboratories- Market Size & Forecast 2020–2030, USD Million
      2. Diagnostic Centers/Stand-alone Labs- Market Size & Forecast 2020–2030, USD Million
      3. Clinics- Market Size & Forecast 2020–2030, USD Million
      4. Home Care- Market Size & Forecast 2020–2030, USD Million
      5. Research Institutes- Market Size & Forecast 2020–2030, USD Million
      6. Others
    3. By Region
      1. Northern
      2. Central
      3. Southern
      4. Southeast
      5. Mekong Delta
    4. By Company
      1. Company Revenue Shares
      2. Competitor Characteristics
Vietnam Immunoassay-Based Diagnostic Tests Market Outlook, 2020–2030
1. Market Size & Outlook
  1. By Revenues (USD Million)
  2. By Volume (Million Units)
    1. By Distribution End Users - Market Size & Forecast 2020–2030, USD Million
Vietnam Molecular Diagnostic Tests Market Outlook, 2020–2030
1. Market Size & Outlook
  1. By Revenues (USD Million)
  2. By Volume (Million Units)
    1. By End Users - Market Size & Forecast 2020–2030, USD Million
Vietnam Clinical Chemistry Diagnostic Tests Market Outlook, 2020–2030
1. Market Size & Outlook
  1. By Revenues (USD Million)
  2. By Volume (Million Units)
    1. By End Users - Market Size & Forecast 2020–2030, USD Million
Vietnam Hematology Diagnostic Tests Market Outlook, 2020–2030
1. Market Size & Outlook
  1. By Revenues (USD Million)
  2. By Volume (Million Units)
    1. By End Users - Market Size & Forecast 2020–2030, USD Million
Vietnam Microbiology Diagnostic Tests Market Outlook, 2020–2030
1. Market Size & Outlook
  1. By Revenues (USD Million)
  2. By Volume (Million Units)
    1. By End Users - Market Size & Forecast 2020–2030, USD Million
Vietnam Rapid/Point-of-Care Diagnostic Tests Market Outlook, 2020–2030
1. Market Size & Outlook
  1. By Revenues (USD Million)
  2. By Volume (Million Units)
    1. By End-Users - Market Size & Forecast 2020–2030, USD Million
Vietnam Diagnostic Tests Market Key Strategic Imperatives for Success & Growth
Competition Outlook
1. Company Profiles
  1. Roche Vietnam Co., Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  2. Siemens Healthineers (Vietnam) Co., Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  3. Abbott Laboratories S.A. (Vietnam)
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  4. Danaher Corporation (Beckman Coulter Vietnam)
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  5. Becton, Dickinson and Company (BD Vietnam)
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  6. Thermo Fisher Scientific (Vietnam)
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  7. Bio-Rad Laboratories (Vietnam)
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  8. Medtronic Vietnam
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  9. Viet A Corporation
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  10. Medicon Co., Ltd
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  11. Sao Thai Duong Joint Stock Company
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO GET THE FREE SAMPLE PAGES

Name *

Email ID *

Country *